News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
407,166 Results
Type
Article (21981)
Company Profile (141)
Press Release (385044)
Multimedia
Podcasts (54)
Webinars (10)
Section
Business (124564)
Career Advice (937)
Deals (27115)
Drug Delivery (80)
Drug Development (54105)
Employer Resources (72)
FDA (9663)
Job Trends (9426)
News (218453)
Policy (19325)
Tag
Academia (1074)
Accelerated approval (3)
Adcomms (6)
Allergies (66)
Alliances (30163)
ALS (71)
Alzheimer's disease (779)
Antibody-drug conjugate (ADC) (104)
Approvals (9733)
Artificial intelligence (233)
Autoimmune disease (21)
Automation (11)
Bankruptcy (210)
Best Places to Work (7280)
BIOSECURE Act (12)
Biosimilars (74)
Biotechnology (70)
Bladder cancer (65)
Brain cancer (22)
Breast cancer (217)
Cancer (1672)
Cardiovascular disease (135)
Career advice (783)
Career pathing (21)
CAR-T (84)
Cell therapy (277)
Cervical cancer (15)
Clinical research (45774)
Collaboration (679)
Company closure (1)
Compensation (314)
Complete response letters (18)
COVID-19 (1463)
CRISPR (33)
C-suite (183)
Cystic fibrosis (70)
Data (1727)
Denatured (15)
Depression (25)
Diabetes (177)
Diagnostics (3094)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (23)
Drug discovery (102)
Drug pricing (80)
Drug shortages (15)
Duchenne muscular dystrophy (71)
Earnings (54132)
Editorial (24)
Employer branding (6)
Employer resources (65)
Events (61512)
Executive appointments (612)
FDA (10658)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (550)
Gene editing (72)
Generative AI (17)
Gene therapy (208)
GLP-1 (522)
Government (2155)
Grass and pollen (5)
Guidances (127)
Healthcare (8651)
Huntington's disease (15)
IgA nephropathy (24)
Immunology and inflammation (68)
Indications (25)
Infectious disease (1555)
Inflammatory bowel disease (95)
Inflation Reduction Act (6)
Influenza (36)
Intellectual property (81)
Interviews (151)
IPO (9814)
IRA (35)
Job creations (2568)
Job search strategy (678)
Kidney cancer (8)
Labor market (18)
Layoffs (294)
Leadership (11)
Legal (4575)
Liver cancer (51)
Lung cancer (231)
Lymphoma (125)
Machine learning (6)
Management (23)
Manufacturing (248)
MASH (50)
Medical device (5668)
Medtech (5670)
Mergers & acquisitions (17845)
Metabolic disorders (454)
Multiple sclerosis (67)
NASH (14)
Neurodegenerative disease (60)
Neuropsychiatric disorders (16)
Neuroscience (1175)
NextGen: Class of 2025 (3098)
Non-profit (1779)
Now hiring (9)
Obesity (236)
Opinion (169)
Ovarian cancer (56)
Pain (78)
Pancreatic cancer (55)
Parkinson's disease (96)
Partnered (12)
Patents (181)
Patient recruitment (75)
Peanut (32)
People (35880)
Pharmaceutical (70)
Pharmacy benefit managers (15)
Phase I (12772)
Phase II (19827)
Phase III (16798)
Pipeline (1073)
Policy (91)
Postmarket research (1765)
Preclinical (4947)
Press Release (32)
Prostate cancer (91)
Psychedelics (11)
Radiopharmaceuticals (173)
Rare diseases (274)
Real estate (3406)
Recruiting (23)
Regulatory (14035)
Reports (24)
Research institute (1146)
Resumes & cover letters (152)
Rett syndrome (4)
RNA editing (2)
RSV (29)
Schizophrenia (69)
Series A (103)
Series B (61)
Service/supplier (6)
Sickle cell disease (43)
Special edition (10)
Spinal muscular atrophy (110)
Sponsored (15)
Startups (2275)
State (2)
Stomach cancer (4)
Supply chain (50)
Tariffs (40)
The Weekly (37)
Vaccines (423)
Venture capitalists (27)
Weight loss (152)
Women's health (14)
Worklife (8)
Date
Last 7 days (720)
Last 30 days (2189)
Last 365 days (23149)
2025 (8981)
2024 (23103)
2023 (24366)
2022 (32136)
2021 (33273)
2020 (31212)
2019 (25466)
2018 (19844)
2017 (20723)
2016 (19111)
2015 (22584)
2014 (17559)
2013 (14433)
2012 (15351)
2011 (16214)
2010 (14760)
Location
Africa (450)
Alabama (27)
Alaska (3)
Arizona (94)
Arkansas (9)
Asia (27112)
Australia (4014)
California (4385)
Canada (1455)
China (387)
Colorado (191)
Connecticut (217)
Delaware (140)
Europe (57797)
Florida (602)
Georgia (127)
Idaho (24)
Illinois (371)
India (21)
Indiana (219)
Iowa (5)
Japan (156)
Kansas (69)
Kentucky (18)
Louisiana (8)
Maine (16)
Maryland (553)
Massachusetts (3288)
Michigan (115)
Minnesota (242)
Mississippi (1)
Missouri (52)
Montana (12)
Nebraska (12)
Nevada (36)
New Hampshire (34)
New Jersey (1377)
New Mexico (15)
New York (1186)
North Carolina (730)
North Dakota (5)
Northern California (1896)
Ohio (123)
Oklahoma (7)
Oregon (21)
Pennsylvania (938)
Puerto Rico (13)
Rhode Island (17)
South America (719)
South Carolina (9)
Southern California (1683)
Tennessee (90)
Texas (614)
United States (16202)
Utah (104)
Virginia (134)
Washington D.C. (46)
Washington State (361)
West Virginia (3)
Wisconsin (55)
407,166 Results for "3m pharmaceuticals acquired by graceway pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
March 5, 2025
·
14 min read
Press Releases
Jabil Acquires Pharmaceutics International, Inc. (Pii)
February 4, 2025
·
4 min read
Press Releases
Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with Acquired Hypothalamic Obesity
April 7, 2025
·
8 min read
Press Releases
Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials
April 15, 2025
·
1 min read
Press Releases
Taiho Pharmaceutical to Acquire Next-Generation ADC Drug Discovery Company Araris Biotech
March 17, 2025
·
7 min read
Press Releases
CASI Pharmaceuticals Announces Receipt of An Updated Non-Binding Proposal to Acquire Entire China Business of the Company
April 3, 2025
·
7 min read
Press Releases
Paratek Pharmaceuticals to Acquire Optinose, Creating Significant Commercial Expansion Opportunities for XHANCE® in Chronic Rhinosinusitis (CRS)
March 20, 2025
·
17 min read
Press Releases
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
December 30, 2024
·
11 min read
Press Releases
Rhythm Pharmaceuticals Announces Pivotal Phase 3 TRANSCEND Trial Meets Primary Endpoint with -19.8% Placebo-adjusted BMI Reduction in Patients (N=120) with Acquired Hypothalamic Obesity
April 7, 2025
·
13 min read
Deals
Cycle Pharmaceuticals Announces All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share
Cycle Pharmaceuticals Ltd today confirmed that it made a proposal to the Board of Directors of Vanda Pharmaceuticals, Inc. (“Vanda”) (NASDAQ: VNDA) on May 24, 2024 to acquire 100% of Vanda’s issued and outstanding shares for a cash consideration of $8.00 per Vanda share, representing a total cash consideration of $466 million.
June 6, 2024
·
5 min read
1 of 40,717
Next
